AmerisourceBergen Corp. (NYSE: ABC), Valley Forge, PA, reported sales for the 2014 fiscal year ended September 30 of $119.6 billion, an increase of 35.9 percent compared to the same period a year ago. Profit decreased 36.3 percent to $276.5 million.
Sales for the quarter were $31.6 billion, an increase of 29.1 percent compared to the same period a year ago. Profit increased 32.9 percent to $67.8 million.
The pharmaceutical distribution segment, which includes AmerisourceBergen Drug Corp. and AmerisourceBergen Specialty Group, had sales of $31 billion in the fourth quarter, an increase of 29 percent compared to the same period a year ago. ABDC revenues increased 33 percent, due primarily to the new Walgreens-branded pharmaceuticals business and a substantial portion of their generic pharmaceuticals business, and increased branded pharmaceutical sales to other large customers. ABSG revenues increased 13 percent, driven by blood products, vaccine and specialty distribution businesses.
AmerisourceBergen’s other segment, which includes AmerisourceBergen Consulting Services and World Courier, had sales of $652.2 million, an increase of 26 percent year-on-year.
